Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
2.
Cureus ; 14(7): e26592, 2022 Jul.
Article in English | MEDLINE | ID: mdl-35936156

ABSTRACT

Pain continues to be a well-known complication of cardiac surgery in the postoperative period and intravenous opioid analgesia has traditionally been employed to manage cardiac surgical pain. However, both components have contributed to a multitude of undesirable adverse effects which can further exacerbate delays in recovery. Often overlooked in the analgesic plan, chest tube pain contributes significantly to the overall postoperative pain from cardiac surgery. Novel regional anesthetic blocks have shown great promise as analgesic adjuncts for cardiothoracic anesthesia but preliminary investigations focus primarily on management of sternotomy pain. Reduction of chest tube pain should be considered while implementing regional blocks to control surgical pain. This study presents a case where the rectus sheath block minimized chest tube pain after aortic valve replacement in conjunction with intercostal nerve blocks and a multimodal analgesic plan.

4.
J Cardiothorac Vasc Anesth ; 35(10): 3085-3097, 2021 10.
Article in English | MEDLINE | ID: mdl-34059437

ABSTRACT

Since the first endovascular aortic repair in 1990, endovascular devices and the indications for their use have significantly grown. Considerable progress has been made in endovascular devices and techniques, such that endovascular repair is now considered first-line treatment for patients with descending aortic disease. However, for patients with ascending aortic disease, open surgical repair with cardiopulmonary bypass and hypothermic cardiac arrest was the only option until recently. Although the outcomes for open surgical repair of the ascending aorta have improved over the years, approximately 30% of patients with an emergent surgical indication, such as type A aortic dissection, are considered to be too high risk for open repair. For these patients, endovascular repair of the ascending aorta offers a life-saving procedure. The ascending aorta is regarded as the final frontier for endovascular therapy. Endovascular repair of it has posed a formidable challenge thus far, due to its unique anatomy, hemodynamic forces, and lack of an appropriate stent-graft designed specifically for the ascending aorta. Although currently there are no comprehensive data from randomized clinical trials, there are several case series and case reports that have shown favorable outcomes. Improvements in available devices soon will drive an exponential increase in the number of patients undergoing endovascular ascending aortic repair. In this review, the authors discuss multiple aspects of endovascular ascending aortic repair including the unique surgical and anesthetic considerations, the devices used, and the available outcomes data, and future directions are also explored.


Subject(s)
Anesthetics , Aortic Aneurysm, Thoracic , Blood Vessel Prosthesis Implantation , Endovascular Procedures , Aorta/diagnostic imaging , Aorta/surgery , Aortic Aneurysm, Thoracic/surgery , Blood Vessel Prosthesis , Humans , Postoperative Complications/surgery , Stents , Treatment Outcome
7.
Eur J Cardiothorac Surg ; 57(6): 1224-1226, 2020 06 01.
Article in English | MEDLINE | ID: mdl-31710660

ABSTRACT

Postpneumonectomy syndrome can have a significant clinical impact on a patient. It presents as progressive dyspnoea due to compression of the contralateral bronchus and/or pulmonary veins. Herein, we present a patient who over a 2-year period developed progressive dyspnoea on exertion and eventually also at rest, due to compression of her left mainstem bronchus and her left inferior pulmonary vein. Surgical correction with implantable adjustable saline implants was undertaken to ameliorate her symptoms. Concurrent use of intraoperative transoesophageal echocardiography permitted real-time adjustment of the implants. This allowed objective measurement and demonstration of normalization of pulmonary vein velocity, which resulted in complete symptom resolution.


Subject(s)
Echocardiography, Transesophageal , Pneumonectomy , Dyspnea , Female , Humans , Pneumonectomy/adverse effects , Prostheses and Implants , Syndrome
9.
A A Pract ; 11(10): 273-275, 2018 Nov 15.
Article in English | MEDLINE | ID: mdl-29894345

ABSTRACT

Chest tube thoracostomy is a commonly performed procedure in the emergency department, operating room, and intensive care unit. We report an extremely rare case of accidental insertion of a chest tube into the left atrium via the right pulmonary vein during an interventional radiology-guided placement of the catheter. To our knowledge, such a case has not been reported to date. The anesthetic and surgical management of this injury are discussed.


Subject(s)
Chest Tubes/adverse effects , Heart Atria/injuries , Iatrogenic Disease , Radiography, Interventional/adverse effects , Thoracostomy/adverse effects , Cardiopulmonary Bypass , Heart Atria/surgery , Humans , Male , Middle Aged , Pneumothorax/surgery , Pulmonary Veins
10.
Semin Cardiothorac Vasc Anesth ; 22(3): 306-323, 2018 Sep.
Article in English | MEDLINE | ID: mdl-29277148

ABSTRACT

Prostacyclin (prostaglandin I2 [PGI2]) is an eicosanoid lipid mediator produced by the endothelial cells. It plays pivotal roles in vascular homeostasis by virtue of its potent vasodilatory and antithrombotic effects. Stable pharmacological analogues of PGI2 are used for treatment of pulmonary hypertension and right ventricular failure. PGI2 dose dependently inhibits platelet activation induced by adenosine-5'-diphosphate, arachidonic acid, collagen, and low-dose thrombin. This property has led to its use as an alternative to direct thrombin inhibitors in patients with type II heparin-induced thrombocytopenia (HIT) undergoing cardiac surgery. The aims of this review are the following: (1) to review the pharmacology of PGI2 and its derivatives, (2) to present the evidence for their use in pulmonary hypertension and right heart failure, and (3) to discuss their utility in the management of HIT in cardiac surgery.


Subject(s)
Cardiac Surgical Procedures , Epoprostenol/therapeutic use , Epoprostenol/administration & dosage , Epoprostenol/pharmacology , Heart Failure/drug therapy , Heparin/adverse effects , Humans , Hypertension, Pulmonary/drug therapy , Prostaglandin-Endoperoxide Synthases/physiology , Thrombocytopenia/drug therapy
11.
JA Clin Rep ; 2(1): 31, 2016.
Article in English | MEDLINE | ID: mdl-29492426

ABSTRACT

Therapeutic plasma exchange (TPE) is a potentially life-saving procedure which effectively removes donor-specific human leukocyte antigen (HLA) antibodies from the bloodstream, allowing critically ill heart transplant recipients to receive a donor organ with less wait time, and reducing the risk of acute organ rejection. The bulk of coagulation factors is initially removed from the blood during TPE using albumin and is later replaced with allogeneic plasma. Coagulopathy may develop during TPE and then can persist due to intraoperative blood loss and hemodilution during surgery and cardiopulmonary bypass. We hereby describe the utility of rotational thromboelastometry to assess rapid coagulation changes during TPE and subsequent heart transplant (HT) surgery.

12.
Curr Opin Anaesthesiol ; 27(1): 49-56, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24322208

ABSTRACT

PURPOSE OF REVIEW: To assess the current status and methods of robotic totally endoscopic coronary artery bypass (TECAB) surgery and discuss important anesthetic considerations. RECENT FINDINGS: Technological and surgical advances in robotics have led to the evolution of TECAB surgery from a single-vessel procedure to quadruple-vessel bypass. TECAB is now a reproducible technique, with a low incidence of mortality and morbidity and superior quality of life. Although early cohorts of patients are still being observed for long-term outcomes, initial and midterm outcomes are comparable to those of conventional coronary artery bypass. TECAB is also associated with specific challenges for the anesthesiologist. SUMMARY: TECAB surgery is a feasible alternative to open coronary artery bypass surgery in selected patient populations. Appropriate patient selection, team training, and stepwise application of the procedure are crucial. TECAB is associated with a unique set of challenges, requiring a skilled operative team. As robotic technology and surgical expertise evolve, this technology will find wider application in an increasing high-risk patient population that will require the support of a skilled anesthesiology team.


Subject(s)
Coronary Artery Bypass/methods , Endoscopy/methods , Robotics , Anesthesia , Echocardiography, Transesophageal , Humans , Insufflation , Monitoring, Intraoperative , Patient Positioning , Perfusion , Preoperative Care , Sternotomy , Treatment Outcome , Ventricular Fibrillation/therapy
13.
J Cardiothorac Vasc Anesth ; 28(3): 647-51, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24290749

ABSTRACT

OBJECTIVES: Diffuse isolated liver metastases are the dominant mode of tumor progression in a number of cancers and present a major treatment challenge for oncologists. An experimental treatment, percutaneous hepatic perfusion (PHP), utilizes partial venovenous cardiopulmonary bypass to allow administration of high-dose chemotherapy directly and solely to the liver with filtration of chemotherapeutic agents from the blood prior to its return to the systemic circulation, thereby minimizing toxic systemic effects. The following case series describes the management of 5 patients with metastatic melanoma undergoing serial PHPs. DESIGN: A single-center experience from a national multi-center random-assignment trial comparing PHP to best alternative care (BAC) in patients with diffuse melanoma liver metastases. SETTING: A tertiary care hospital. PARTICIPANTS: Five patients with metastatic melanoma to the liver. INTERVENTION: Five patients underwent a total of fifteen PHPs using a venovenous bypass circuit with hemofiltration, receiving hepatic intra-arterial melphalan, 3 mg/kg of ideal body weight, for 30 minutes with a total of 60 minutes of hemofiltration. MEASUREMENTS AND MAIN RESULTS: Five patients tolerated the procedure well with transient hemodynamic and metabolic changes. CONCLUSIONS: In patients with diffuse isolated liver metastases, PHP is a safe and well-tolerated procedure that can be performed more than once and is associated with marked anti-tumor activity in some patients.


Subject(s)
Cardiopulmonary Bypass/methods , Liver Neoplasms/secondary , Melanoma/secondary , Perfusion/methods , Antineoplastic Agents, Alkylating/administration & dosage , Antineoplastic Agents, Alkylating/therapeutic use , Body Temperature/physiology , Catheterization , Female , Hemofiltration , Humans , Liver Circulation , Liver Neoplasms/drug therapy , Liver Neoplasms/surgery , Male , Melanoma/drug therapy , Melanoma/surgery , Melphalan/administration & dosage , Melphalan/therapeutic use , Middle Aged
15.
J Cardiothorac Vasc Anesth ; 27(3): 586-99, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23672862

ABSTRACT

Over the last decade, TECAB has matured into a reproducible technique associated with low incidence of both mortality and morbidity, as well as superior quality of life, when compared with open CABG surgery. However, TECAB also is associated with important and specific challenges for the anesthesiology team, particularly with regard to the physiologic stresses of OLV, placement of special catheters, and induced capnothorax. As the technology supporting robotic surgery evolves and familiarity with, and confidence in, TECAB increases, the authors anticipate increasingly widespread use of these procedures in an increasingly fragile and problematic patient population who will require the support of a skilled and vigilant anesthesiology team.


Subject(s)
Anesthesia , Cardiac Surgical Procedures/methods , Endoscopy/methods , Robotics , Cardiac Surgical Procedures/economics , Cardiac Surgical Procedures/instrumentation , Coronary Artery Disease/surgery , Endoscopy/economics , Endoscopy/instrumentation , Humans , Intraoperative Complications/therapy , Monitoring, Intraoperative , One-Lung Ventilation , Preoperative Care , Robotics/economics , Robotics/instrumentation , Treatment Outcome
17.
Ann Thorac Surg ; 79(1): 339-41, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15620977

ABSTRACT

Atrioventricular groove tear or disruption is a disastrous and technically challenging complication after mitral valve replacement surgery. This report details the untimely spontaneous occurrence of an atrioventricular tear during manipulation of the heart for off-pump coronary artery bypass grafting and its successful repair. Significant distortion of the mitral annulus and elevation of pulmonary artery pressures in the beating heart likely contributed to the spontaneous tear.


Subject(s)
Coronary Artery Bypass, Off-Pump , Heart Injuries/surgery , Internal Mammary-Coronary Artery Anastomosis , Intraoperative Complications/surgery , Aged , Anticoagulants/adverse effects , Arginine/analogs & derivatives , Cardiopulmonary Bypass , Coronary Stenosis/complications , Coronary Stenosis/surgery , Emergencies , Fatal Outcome , Female , Heart Injuries/etiology , Heparin/adverse effects , Humans , Hypertension, Pulmonary/complications , Intraoperative Complications/etiology , Mitral Valve/surgery , Myocardial Infarction/etiology , Pipecolic Acids/therapeutic use , Postoperative Complications/etiology , Rupture, Spontaneous , Sulfonamides , Suture Techniques , Thrombocytopenia/chemically induced , Thrombocytopenia/complications , Thromboembolism/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...